• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON CONSUMER INC BAB TOUGH STRIPS; TAPE AND BANDAGE, ADHESIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON CONSUMER INC BAB TOUGH STRIPS; TAPE AND BANDAGE, ADHESIVE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Burn(s) (1757); Erythema (1840); Pain (1994); Peeling (1999)
Event Type  Injury  
Manufacturer Narrative
Device was used for treatment, not diagnosis.Patient age at time of event, weight and ethnicity were not provided for reporting.Report is for one (1) band-aid tough strips unspecified usa not applicable batgztusunsp, lot number n/a.Upc, lot number and udi are not available.Device is not expected to be returned for manufacturer review/investigation.Device evaluation/investigation could not be completed; no conclusion could be drawn as product was not returned to manufacturer.Device history records review could not be completed without lot number.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Consumer¿s attorney reported an event with band-aid tough strip.Consumer used product for 23 hours on his left arm near a burn and a 2 inch by 2 inch piece of the skin of his arm peeled off, causing excruciating pain and doctor visits.When consumer tried to peel of product off his arm, the skin (very deep) will peel off with product.No additional information is known at this time.
 
Manufacturer Narrative
Johnson & johnson consumer, inc.Is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which johnson & johnson consumer, inc.Has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, johnson & johnson consumer, inc.Or its employees that the report constitutes an admission that the device, johnson & johnson consumer, inc., or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.Additional information: a1: patient date of birth ¿ (b)(6) 1956.B5: additional information received from consumer on october 26, 2021, and it was reported that consumer was also experiencing burn during removal of bab tough strips, 10 count.No additional information is known at this time.D10: concomitant medical products: rosuvastatin calcium; losartan potassium; bupropion; venlafaxine; quetiapine fumarate.If information is obtained that was not available for the follow-up #1 medwatch, an additional follow- up medwatch will be filed as appropriate.
 
Event Description
Additional information received from consumer on october 26, 2021, and it was reported that consumer was also experiencing burn during removal of bab tough strips, 10 count and tender to palpation erythema.Additionally, it was reported that consumer was healing well and started mupirocin 2% external ointment for treatment.No additional information is known at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAB TOUGH STRIPS
Type of Device
TAPE AND BANDAGE, ADHESIVE
Manufacturer (Section D)
JOHNSON & JOHNSON CONSUMER INC
199 grandview rd
skillman NJ 08558 9418
Manufacturer (Section G)
BRAZIL CONSUMER
rodovia presidente dutra km 15
são josé dos campos
BR  
Manufacturer Contact
laurie rauco
199 grandview rd
skillman, NJ 08558-9418
2152734905
MDR Report Key12527052
MDR Text Key273761386
Report Number8041154-2021-00034
Device Sequence Number1
Product Code KGX
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Date Manufacturer Received10/26/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Patient Sequence Number1
Treatment
BUPROPION; LOSARTAN POTASSIUM; QUETIAPINE FUMARATE; ROSUVASTATIN CALCIUM; VENLAFAXINE
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-